ELOM-080

About Pohl-Boskamp

Pohl-Boskamp is a privately held, commercial-stage German pharmaceutical company with a century-long heritage, notably as the originator of Nitrolingual®. It has evolved from a traditional generic drug producer into an innovative player combining established therapeutics with a growing portfolio of digital health applications (DiGAs). The company's strategy leverages its strong brand management, in-house development and manufacturing, and strategic partnerships to address therapeutic areas including cardiology, otology, pulmonology, and pain management.

Therapeutic Areas